High-Dose Melphalan Treatment Increases Mutational Burden at Relapse in Patients With Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
High-Dose Melphalan Treatment Significantly Increases Mutational Burden at Relapse in Multiple Myeloma
Blood 2023 Jan 05;[EPub Ahead of Print], MK Samur, M Roncador, A Aktas Samur, M Fulciniti, AH Bazarbachi, RE Szalat, MA Shammas, AS Sperling, PG Richardson, F Magrangeas, S Minvielle, A Perrot, J Corre, P Moreau, A Thakurta, G Parmigiani, KC Anderson, H Avet-Loiseau, NC MunshiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.